Acuitas Therapeutics Is A Biotechnology Company Based In Vancouverspecializing In Lipid Nanoparticlelnpdelivery Systems For Nucleic Acid Therapeuticsfounded In 2009 By Drthomas Maddendrpieter Cullisand Drmichael Hopeacuitas Focuses On Advancing Drug Delivery Technologies Through Strategic Partnerships With Biopharmaceutical Firms The Company Is Recognized For Its Lnp Technologywhich Has Been Clinically Validated In Approved Products Like Onpattroaand Comirnatya Acuitas Develops Optimized Lnp Formulations For The Intracellular Delivery Of Nucleic Acidsincluding Sirnamrnaand Dnawhile Minimizing Toxicitythey Offer Comprehensive Support To Partnersincluding Formulation Optimizationpreclinical Testingand Regulatory Strategywith A Strong Innovation Pipelineacuitas Has Synthesized Over 500 Novel Cationic Lipidscontributing To The Development Of Diverse Therapeutic Applicationstheir Commitment To Collaboration And Scientific Advancement Positions Them As A Leader In The Field Of Nucleic Acid Based Medicine
